Terry Booth, a Senior Officer and 10% Holder, acquired 1,411,764 Common Shares on a direct ownership basis at a price of $0.170 through a private transaction on December 8th, 2021. This represents a $240,000 investment into the company's shares and an account share holdings change of 48.4%.
Australis Capital is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Australis Capital Inc is a Canada-based company engaged in alternative medicine business sector. The Company identifies and invests in the cannabis industry predominately in the United States. It is focused on opportunities with respect to production, processing, extracting of derivatives and sale of both medicinal and recreational cannabis.
No Comments